These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24206223)

  • 1. Biomarker discovery and validation: the tide is turning.
    Nice E
    Expert Rev Proteomics; 2013 Dec; 10(6):505-7. PubMed ID: 24206223
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative mass spectrometry for colorectal cancer proteomics.
    Martínez-Aguilar J; Chik J; Nicholson J; Semaan C; McKay MJ; Molloy MP
    Proteomics Clin Appl; 2013 Jan; 7(1-2):42-54. PubMed ID: 23027722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics and proteomics approaches for biomarker discovery in sporadic colorectal cancer with metastasis.
    González-González M; Garcia JG; Montero JA; Fernandez LM; Bengoechea O; Muñez OB; Orfao A; Sayagues JM; Fuentes M
    Cancer Genomics Proteomics; 2013; 10(1):19-25. PubMed ID: 23382583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery and validation of colorectal cancer biomarkers.
    Ang CS; Phung J; Nice EC
    Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection.
    Nielsen HJ; Brünner N; Frederiksen C; Lomholt AF; King D; Jørgensen LN; Olsen J; Rahr HB; Thygesen K; Hoyer U; Laurberg S; Christensen IJ; ;
    Scand J Gastroenterol; 2008; 43(2):242-8. PubMed ID: 18224568
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing proteomics-based biomarkers for colorectal neoplasms for clinical practice: opportunities and challenges.
    Luo Y; Wang L; Wang J
    Proteomics Clin Appl; 2013 Jan; 7(1-2):30-41. PubMed ID: 23255431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors.
    Lind GE; Ahlquist T; Lothe RA
    Gastroenterology; 2007 Apr; 132(4):1631-2; author reply 1632. PubMed ID: 17408629
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.
    Koshiyama A; Ichibangase T; Imai K
    Biomed Chromatogr; 2013 Apr; 27(4):440-50. PubMed ID: 22991145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity--a prognostic factor in colorectal cancer?
    Brümmendorf TH
    Onkologie; 2005 Nov; 28(11):550-1. PubMed ID: 16249639
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteomic analysis of colorectal cancer: discovering novel biomarkers.
    Skandarajah AR; Moritz RL; Tjandra JJ; Simpson RJ
    Expert Rev Proteomics; 2005 Oct; 2(5):681-92. PubMed ID: 16209648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer proteomics, molecular characterization and biomarker discovery.
    Barderas R; Babel I; Casal JI
    Proteomics Clin Appl; 2010 Feb; 4(2):159-78. PubMed ID: 21137041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin.
    Xing X; Lai M; Gartner W; Xu E; Huang Q; Li H; Chen G
    Proteomics; 2006 May; 6(9):2916-23. PubMed ID: 16586428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of molecular biomarkers in individualized treatment of colorectal cancer.
    De Mattos-Arruda L; Dienstmann R; Tabernero J
    Clin Colorectal Cancer; 2011 Dec; 10(4):279-89. PubMed ID: 21729679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics beyond proteomics: toward clinical applications.
    Plymoth A; Hainaut P
    Curr Opin Oncol; 2011 Jan; 23(1):77-82. PubMed ID: 21107258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression in colorectal cancer.
    Hogan NM; Joyce MR; Kerin MJ
    Cancer Biomark; 2012; 11(6):239-43. PubMed ID: 23248181
    [No Abstract]   [Full Text] [Related]  

  • 16. Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry.
    Jankova L; Chan C; Fung CL; Song X; Kwun SY; Cowley MJ; Kaplan W; Dent OF; Bokey EL; Chapuis PH; Baker MS; Robertson GR; Clarke SJ; Molloy MP
    Mol Biosyst; 2011 Nov; 7(11):2997-3005. PubMed ID: 21808808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARG: a new independent marker for colorectal cancer survival.
    Girnun G
    Gastroenterology; 2009 Apr; 136(4):1157-60. PubMed ID: 19236969
    [No Abstract]   [Full Text] [Related]  

  • 18. SCRN1: a biomarker for colorectal cancer?
    Wiwanitkit V
    J Surg Oncol; 2010 Jun; 101(7):643. PubMed ID: 20461775
    [No Abstract]   [Full Text] [Related]  

  • 19. [Omics docking and molecular classification in colorectal cancer].
    Peng Y; Shen S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 35(11):1201-6. PubMed ID: 21131745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer?
    Toriola AT; Ulrich CM
    Future Oncol; 2011 Oct; 7(10):1125-8. PubMed ID: 21992725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.